Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate

Comparative mitochondrial proteomics: perspective in human diseases

(2012) Yujie Jiang et al.   Journal of Hematology & Oncology

HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas

(2012) Angela M Sosin et al.   Journal of Hematology & Oncology

Alterations in the ribosomal machinery in cancer and hematologic disorders

(2012) Niraj Shenoy et al.   Journal of Hematology & Oncology

Expression of Tubb3, a Beta-Tubulin Isotype, Is Regulated by Androgens in Mouse and Rat Sertoli Cells1

(2011) Karel De Gendt et al.   BIOLOGY OF REPRODUCTION

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells

(2011) Ratana Banjerdpongchai et al.   Journal of Hematology & Oncology

Unfolded protein response in cancer: the Physician's perspective

(2011) Xuemei Li et al.   Journal of Hematology & Oncology

Mitochondrial configurations in peripheral nerve suggest differential ATP production

(2010) Guy A. Perkins et al.   JOURNAL OF STRUCTURAL BIOLOGY

Mitochondrial Rejuvenation After Induced Pluripotency

(2010) Steven T. Suhr et al.   PLoS One

Atg5 Regulates Phenethyl Isothiocyanate-Induced Autophagic and Apoptotic Cell Death in Human Prostate Cancer Cells

(2009) A. Bommareddy et al.   CANCER RESEARCH

Electron microscopy morphology of the mitochondrial network in human cancer

(2009) Gabriel Arismendi-Morillo   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Covalent Binding to Tubulin by Isothiocyanates

(2008) Lixin Mi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways

(2008) Quanyi Lu et al.   Journal of Hematology & Oncology

Proteomic characterization of cytoskeletal and mitochondrial class III  -tubulin

(2008) L. Cicchillitti et al.   MOLECULAR CANCER THERAPEUTICS